Boji Medical Technology Co., Ltd Boji Medical Technology Co., Ltd
News

News

Company News

One-Stop Full-Process CRO+CDMO Service Provider for Innovative Drugs and Medical Devices

Company News

BojiMed and Huawei Sign Cooperation Agreement to Jointly Build a New AI+CRO Intelligent R&D Paradigm
2026-09-03

BojiMed and Huawei Sign Cooperation Agreement to Jointly Build a New AI+CRO Intelligent R&D Paradigm

Boji
2026-08-05

Boji's Expert Stewardship | Astem-101 Stem Cell Therapy Investigator Seminar Concludes with Resounding Success

Omalizumab for Injection (Shuyang Shule®) Approved for Market Launch! BojiMed Supports Its Phase III Clinical Research
2026-08-04

Omalizumab for Injection (Shuyang Shule®) Approved for Market Launch! BojiMed Supports Its Phase III Clinical Research

BojiMed Signs Phase I–II Clinical Project Agreement with Beijing Shunxin Xiangyu for Active Inflammatory Bowel Disease, Opening a New Chapter of In-Depth Collaboration
2026-08-03

BojiMed Signs Phase I–II Clinical Project Agreement with Beijing Shunxin Xiangyu for Active Inflammatory Bowel Disease, Opening a New Chapter of In-Depth Collaboration

BojiMed Named Among China
2026-06-29

BojiMed Named Among China's Top 10 Pharmaceutical CRO Enterprises for 2026 (Ranked 8th)

BojiMed Contributes to World
2026-06-04

BojiMed Contributes to World's First Transcriptome-Based Standard for Medicinal Resource Discovery

Delegation from Sweden’s Uppsala Monitoring Centre Visits Boji Medical Beijing for In-Depth Discussions
2026-06-03

Delegation from Sweden’s Uppsala Monitoring Centre Visits Boji Medical Beijing for In-Depth Discussions

Boji Medical Wins CGCS Rising Star Award for Best CRO Partner in CGT Sector
2026-06-01

Boji Medical Wins CGCS Rising Star Award for Best CRO Partner in CGT Sector

Boji Medical Provides Full-Program Support as Arnovie101 Shows Positive Early Clinical Signals with Favorable Efficacy and Safety Profile
2026-05-28

Boji Medical Provides Full-Program Support as Arnovie101 Shows Positive Early Clinical Signals with Favorable Efficacy and Safety Profile

Boji Medical Supports Clinical Trial Approval of World’s First iPSC-Derived Renal Cell Therapy
2026-05-21

Boji Medical Supports Clinical Trial Approval of World’s First iPSC-Derived Renal Cell Therapy

Previous :

Next :

Close